MESOTHELIOMA
Clinical trials for MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients get chance to continue promising drug in Long-Term safety study
Disease control CompletedThis study allowed patients with various cancers who had benefited from the drug tazemetostat in earlier trials to continue receiving it. The main goal was to monitor the drug's long-term safety in these patients. It was open to people who had not seen their cancer worsen and cou…
Matched conditions: MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat mesothelioma: targeted chemo shows promise
Disease control CompletedThis study tested whether delivering chemotherapy drugs directly to the tumor through blood vessels could help control advanced pleural mesothelioma. The trial involved 34 adults whose cancer couldn't be removed by surgery and who hadn't responded to standard chemotherapy. Resear…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
New hope in fight against deadly asbestos cancer
Disease control CompletedThis study tested whether adding an immunotherapy drug called durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. Pleural mesothelioma is an aggressive cancer often linked to asbestos exposure, with limited treatment options. The trial…
Matched conditions: MESOTHELIOMA
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC